Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 1, 2004; 10(15): 2284-2286
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2284
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2284
Group | Patients below normal (%) (Reference range) | Patients above normal (%)Reticulocytes (5-20%) | ||
Erythrocytes (4.5-5.9 T/L) | Hct (40-50%) | Hb (13-17 g/dL) | ||
Cirrhosis (n = 15) | 46 | 53 | 40 | 0 |
Chronic hepatitis (n = 10) | 30 | 30 | 30 | 0 |
Chronic hepatitis /ribavirin (n = 10) | 80 | 80 | 70 | 30 |
Measured MBG (mmol/L) | Menarini HA-8140 Calculated MBG (mmol/L) | DCA 2000 Bayer Calculated MBG (mmol/L) | |
Cirrhosis (n = 15) | 5.8 ± 1.9 | 4.8 | 5.1 |
Chronic hepatitis (n = 10) | 5.1 ± 0.3 | 5.4 | 5.4 |
Chronic hepatitis /Ribavirin (n = 10) | 5.2 ± 0.4 | 4.3 | 4.5 |
- Citation: Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10(15): 2284-2286
- URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2284.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2284